Review
Copyright ©The Author(s) 2015.
World J Gastrointest Pharmacol Ther. Nov 6, 2015; 6(4): 183-198
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.183
Table 1 Decline in rates of Helicobacter pylori eradication following first-line standard triple therapy
CountryRef.PublicationTreatment durationPatientsTherapy regimenEradication rate (ITT)Eradication rate (PP)
South KoreaNa et al[177]20077 d3267Standard PPINA84.3%
Cla 500 mg bid
Amo 1 g bid
Chung et al[178]201210 d80Lan 30 mg bid58.7%67.6%
Cla 500 mg bid
Amo 1 g bid
JapanAsaka et al[179]20017 d96Lan 30 mg bidNA90.7%
Cla 200 mg bid
Amo 750 mg bid
Fujioka et al[180]20127 d3162Rab 10 mg bid80.7%NA
Amo 750 mg bid
Cla 200 mg bid
Nishizawa et al[27]20127 d55Lan 30 mg bid74.5%80.4%
Cla 400 mg bid
Amo 750 mg bid
Nishida et al[181]20147 d134/134Eso 20 mg bid69.4%/73.9%76.9%/79.8%
Cla 400 mg bid
Amo 750 mg bid
Lan 30 mg bid
Cla 400 mg bid
Amo 750 mg bid
TaiwanSheu et al[182]20007 d or 2 wk286Ome 20 mg bidNA87.8%
Amo 1 g bid
Cla or Met bid
Chen et al[117]20147 d73Rab 20 mg bid57.5%61.8%
Cla 500 mg bid
Amo 1 g bid
TurkeyOzçay et al[183]20044 wk: PPI 2 wk:Cla, Amo102Ome or LanNA75.7%
Cla 7.5 mg/kg bid
Amo 20 mg/kg bid
Kutluk et al[184]201410 d74Lan 1 mg/kg per day52.7%55.7%
Cla 20 mg/kg per day
Amo 50 mg/kg per day
ItalyCatalano et al[185]199910 d84Ome 20 mg bidNA94.0%
Cla 500 mg bid
Amo 1 g bid
Paoluzi et al[186]20107 d90Eso 20 mg bid66.0%75.0%
Cla 500 mg bid
Amo 1 g bid
Latin AmericaGreenberg et al[106]201114 d488Lan 30 mg bid82.2%87.1%
Cla 500 mg bid
Amo 1 g bid
Table 2 Helicobacter pylori eradication rates following first-line sequential therapy
CountryRef.PublicationTreatment durationPatientsTherapy regimenEradication rate (ITT)Eradication rate (PP)
South KoreaLee et al[92]201410 d1111st 5 d: Eso + Amo72.1%78.4%
2nd 5 d: Eso + Cla + Met
Lee et al[91]201510 d1001st 5 d: Rab + Amo79.0%84.9%
2nd 5 d: Rab + Cla + Met
ChinaZhou et al[93]201410 d1401st 5 d: Eso + Amo72.1%76.5%
2nd 5 d: Eso + Cla + Tin
QatarBen Chaabane et al[94]201514 d1061st 7 d: Rab + Amo66.0%76.0%
2nd 7 d: Rab + Cla + Met
ItalyPontone et al[187]201010 d841st 5 d: Lan + Amo83.3%90.9%
2nd 5 d: Lan + Cla + Met
SpainMolina-Infante et al[114]201010 d1151st 5 d: Ome + Amo76.5%80.8%
2nd 5 d: Ome + Cla + Met
Table 3 Helicobacter pylori eradication rates following first-line concomitant therapy
CountryRef.PublicationTreatment durationPatientsTherapy regimenEradication rate (ITT)Eradication rate (PP)
South KoreaLim et al[104]201314 d78Rab 20 mg bid80.8%81.3%
Amo 1 g bid
Cla 500 mg bid
Met 500 mg bid
Lee et al[100]20157 d170Rab 20 mg bid79.4%94.4%
Amo 1 g bid
Cla 500 mg bid
Met 500 mg tid
ThailandKongchayanun et al[188]20125 d/10 d55/55Rab 20 mg bid89.1%/96.4%NA
Amo 1 g bid
Met 400 mg tid
Cla 1 g qd
SingaporeAng et al[102]201510 d153PPI standard does81.7%95.4%
Amo 1 g bid
Cla 500 mg bid
Met 400 mg bid
SpainMolina-Infante et al[97]201210 d209PPI standard does87.0%89.0%
Amo 1 g bid
Cla 500 mg bid
Met 500 mg bid
McNicholl et al[103]201410 d168Ome 20 mg bid87.0%91.0%
Amo 1 g bid
Cla 500 mg bid
Met 500 mg bid
Latin AmericaGreenberg et al[106]20115 d489Lan 30 mg bid73.6%NA
Amo 1 g bid
Cla 500 mg bid
Met 500 mg bid
Table 4 Helicobacter pylori eradication rates following first-line levofloxacin-containing therapy
CountryRef.PublicationTreatment durationPatientsTherapy regimenEradication rate (ITT)Eradication rate (PP)
South KoreaChoi et al[189]20117 d98Ome 20 mg bid65.3%73.6%
Lev 200 mg bid
Amo 1 g bid
ChinaLiao et al[122]201314 d81Lan 30 mg bid82.7%85.9%
Lev 500 mg qd
Amo 1 g bid
TaiwanLiou et al[190]20107 d217Lan 30 mg bid74.2%80.1%
Lev 750 mg qd
Amo 1 g bid
Chen et al[117]20147 d73Rab 20 mg bid78.1%80.9%
Lev 500 mg bid
Amo 1 g bid
SpainMolina-Infante et al[114]201010 d115Ome 20 mg bid80.8%82.6%
Lev 500 mg bid
Amo 1 g bid